Mediterr J Rheumatol 2023;34(3):302-14
Recommendations of the Moroccan Society of Rheumatology (SMR) for Diagnostic Management of Spondyloarthritis (SpA) and Psoriatic Arthritis (PsA)
Authors Information

1Department of Rheumatology A, El Ayachi Hospital, Ibn Sina University Hospital, Salé, Morocco

2Private Medical Office, Rabat, Morocco

3Department of Rheumatology, Military Hospital Avicenne, Mohammed VI University Hospital, Marrakech, Morocco

4Department of Rheumatology, Arrazi University Hospital, Marrakech, Morocco

5Private Medical Office, Rabat, Morocco

6Department of Rheumatology, Mohammed VI University Hospital, Oujda, Morocco

7Department of Rheumatology, Ibn Rochd University Hospital, Casablanca, Morocco

8Department of Rheumatology, Tanger-Tetouan- Al Hoceima University Hospital, Tanger, Morocco

9Department of Rheumatology, Hassan II University Hospital, Fès, Morocco

10Department of Rheumatology, University Hospital Hassan II-Souss Massa, Agadir, Morocco

11CARBONE research team, LARISS Laboratory, FMPA, Ibn Zohr University, Agadir-Morocco

12Department of physical medicine and rehabilitation, El Ayachi Hospital, Ibn Sina University Hospital, Salé, Morocco

13Department of Rheumatology, Military Hospital Mohammed V, Ibn Sina University Hospital, Rabat, Morocco

14 Health Sciences College, International University of Rabat (UIR), Rabat, Morocco

15Department of Rheumatology, Provincial Hospital of Temara, Temara, Morocco


In 2017, the Moroccan Society of Rheumatology (SMR) issued guidelines for the treatment of severe ankylosing spondylitis. The emergence of new therapeutic classes, the update of international guidelines for axial SpA and psoriatic arthritis, and the diagnostic and therapeutic challenges encountered by rheumatologists has led to the development of recent SMR guidelines for the management of SpA patients. A group-work included rheumatologists, specialists in physical medicine and rehabilitation, and epidemiologists from various sectors was tasked with writing these recommendations based on a literature review, then adapting them to the national context. Thus, 33 recommendations were selected and organised into two sections: diagnostic and therapeutic. The diagnostic section included three general principles and fourteen recommendations. The first, second, and third recommendations concerned the definition and diagnostic criteria for psoriatic arthritis and psoriatic arthritis. In the management of SpA, Recommendation 4 prioritised the importance of opportunity windows. Recommendation 5 concerned the diagnostic and prognostic significance of HLAB27. The sixth and seventh recommendations related to imaging of the sacroiliac joints and the spine. The eighth recommendation focuses on the diagnosis and evaluation of perivascular thrombosis activity. The ninth and tenth recommendations concerned the evaluation of SpA activity and psoriatic arthritis. The eleventh and twelfth recommendations concern the evaluation of function and structural progression. Recommendation 13 concerned the diagnosis and treatment of coxitis. Recommendation 14 focuses on the most common co-morbidities and extra-rhinitological manifestations observed in SpA.

Cite this article as: Bentaleb I, Oulkadi L, Jaouad N, El Maghraoui A, Niamane R, El Bouchti I, Larhrissi S, Ichchou L, Janani S, Abourazzak F, Akasbi N, Erraoui M, Karkouri S, Bezza A, Hmamouchi I, Bahiri R. Recommendations of the Moroccan Society of Rheumatology (SMR) for Diagnostic Management of Spondyloarthritis (SpA) and Psoriatic Arthritis (PsA). Mediterr J Rheumatol 2023;34(3):302-14.

Article Submitted: 18 Oct 2022; Revised Form: 2 Jun 2023; Article Accepted: 4 Jun 2023; Available Online: 29 Sep 2023


This work is licensed under a Creative Commons Attribution 4.0 International License.

©2023 The Author(s).